Is Amgen (AMGN)’s Acquisition of Celgene’s Medicine A Boost For Biotech Stocks?…
Browsing Category
Featured
949 posts
Stay up to date with our most trending content released multiple times a day, seven days a week. Our featured content presents a witty, well-informed approach to news from all spaces and industries. Written by our elite team of experts, we only give our readers content that is relevant, intellectually stimulating, and designed to give you what you need to converse with even the most jargon-heavy of industry professionals.
Is Amgen (AMGN)’s Acquisition of Celgene’s Medicine A Boost For Biotech Stocks?
When it comes to the biggest pharmaceutical companies in the world, then…
1 Stock is Positioning to Disrupt a Billion Dollar Industry Creating Opportunity & Saving Lives
The Weapons Detection market is expected to grow to nearly $7.5 billion by 2025 and for investors, it could signal big opportunities.
Stock Price Newsletter – Hurricane Dorian Edition
3 Biotech Stocks To Watch This Month The spending on cancer treatments…
Should You Buy Tesla (TSLA) After The Recent Consolidation?
It has been a bit of an up and down year for…
Is Facebook (FB) Stock Price Rated A Buy After The Recent Fall?
Social media giant Facebook, Inc. Common Stock (FB Stock Report) remains one…
2 Cybersecurity Stocks to Watch as the Sector Picks Up Momentum
As the world has become more connected, most workplaces, businesses, large corporations,…
Stock Price Newsletter – August 29, 2019
It’s all about biotech today 3 Biotech Stocks To Watch Heading Into…
PharmaCyte Biotech (PMCB) Confirms Dr. Manuel Hidalgo Will Be Principal Investigator for Clinical Trial in Pancreatic Cancer
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (PMCB), a biotechnology company focused…
Stock Price Newsletter – August 28, 2019
Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could…